iMedicor, Inc., founders of the newly-launched National Healthcare Communications Network (“NHCN”), announced that it has signed a contract with the Stone Center, a New Jersey-based group of 120 urologists, to its NHCN, representing the first Independent Physician Association (“IPA”) to join the network.
The signing of the Stone Center represents a significant milestone for iMedicor as the large organization will not only generate additional revenues for the Company, but will show potential clients how they can leverage the iMedicor platform to enhance performance and efficiency through the NHCN. All medical practices within the Stone Center group will be using the Network with installation and training processes scheduled to start by the end of the month. The initial contract is fifteen months in length and entails iMedicor assisting the Stone Center administrative team with setup and installation along with proper training, backup and technical and customer support.
The National Healthcare Communications Network was launched in September 2010 and is a Health Insurance Portability and Accountability Act (HIPAA) compliant transport and communications network which is designed to move electronic medical records to a secure environment. The Network enables physicians, administrators and other qualified healthcare professionals to exchange medical records, files and images and allows disparate electronic medical record (EMR) systems to integrate and share data. Additionally, iMedicor delivers important information on new drugs and treatments to its members as well as the members of its syndicated partners through their ClearLobby platform. iMedicor is hoping to capitalize on federal mandates that is requiring medical records to be transferred into a digital format in the near future.
Technically speaking, the VMCI chart touched a new 52-week low of $0.0052 two days ago, but has put together a rebound back to $0.0065 in the last two trading sessions. The indicators are giving signals that at least a temporary bounce may be coming, so traders will be watching to see how this news impacts the price per share and if volume can get a lift.
More information on iMedicor and its technologies is available on the Company’s website at www.imedicor.com.
Legal Notice / Disclaimer
This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. Andrew Klips (“the author”) has based this document on information obtained from sources he believes to be reliable, but which has not been independently verified; the author makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author only and are subject to change without notice. The author assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, the author assumes no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information provided within this Report.
The author does not own shares of iMedicor, Inc.
No comments:
Post a Comment